Porr/Strabag do not take over Vamed Austria division after all

The purchase agreement concluded by an investment company was "revoked today, as the implementation could not take place as intended," Strabag announced. Porr will take over Vamed's Austrian project development business as well as the thermal spa holdings in Austria.

Strabag may take over AKH operations management alone

According to the German healthcare group Fresenius, which currently owns Vamed's core business as the seller, the sale will be "accelerated and simplified" by the new approach. "The new agreement is still subject to regulatory approval," said the German healthcare group. According to APA information, the planned sale has not yet been registered with the responsible EU Commission - neither in the originally planned nor in the current configuration. This is evident from a corresponding database of the Brussels authority.

Strabag is now negotiating alone to acquire Vamed-KMB Krankenhausmanagement und Betriebsführungsges.m.b.H. with the business areas of AKH Vienna technical operations management and the construction projects of AKH Vienna. There are also constructive discussions with the Vienna Health Association (WIGEV), according to Strabag. As recently reported by the "Kurier", there were concerns in the Vienna City Hall that the two construction companies, by purchasing the technical operations management of AKH Vienna, want to secure construction contracts for renovations, new constructions, and extensions planned until 2030 worth 1.4 billion euros.

"Vitality-World" thermal spas go to Porr

The Vamed thermal spas in Austria include the "Vitality-World" thermal spas in Vienna, Geinberg, Längenfeld, Kaprun, Laa, and the St. Martins Therme in Frauenkirchen. According to Porr, the purchase price will be a symbolic euro. Additionally, the companies will be further capitalized to offset liabilities, the construction company explained in a statement on Friday. The Austrian project development business includes consulting and project services in the healthcare sector.

The purchase of Vamed's core company by Porr and Strabag, announced in May 2024, was delayed due to the lack of approval by the competition authorities. The German healthcare group Fresenius wants to completely separate from its Austrian subsidiary Vamed. In February, the sale of the international Vamed project business Health Tech Engineering (HTE) to the Worldwide Hospitals Group (WWH) was completed. The Vamed rehabilitation clinics were sold to the French financial investor PAI Partners in autumn 2024. The hospital services business was integrated into the Vamed parent company Fresenius.

(APA/Red)

This article has been automatically translated, read the original article here.